FOX NEWS: Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says


Novavax COVID-19 vaccine 90.4% effective in clinical trial, company says



Novavax announced on Monday that its COVID-19 vaccine was found to be over 90% effective overall, and offered 100% protection against moderate and severe disease in a Phase 3 clinical trial.

via FOX NEWS https://ift.tt/35i7kz9

Subscribe for New Updates

* indicates required

Comments

Popular posts from this blog

Statement on the Nobel Prize in Chemistry 2020

NSF awards $250 million to early career researchers

Zoom media briefing: The Event Horizon Telescope, a year after capturing the image of a black hole